The evolving role of biosimilars in haematology-oncology: a practical perspective.
about
Tbo-Filgrastim: A Review in Neutropenic Conditions.Physicochemical and biological characterization of SB2, a biosimilar of Remicade® (infliximab).Safety Profile of Biosimilar Filgrastim (Zarzio/Zarxio): A Combined Analysis of Phase III Studies.A retrospective open-label uncontrolled study of Epoetin zeta on the treatment of chemotherapy-induced anemia in solid tumors.
P2860
The evolving role of biosimilars in haematology-oncology: a practical perspective.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
The evolving role of biosimilars in haematology-oncology: a practical perspective.
@ast
The evolving role of biosimilars in haematology-oncology: a practical perspective.
@en
type
label
The evolving role of biosimilars in haematology-oncology: a practical perspective.
@ast
The evolving role of biosimilars in haematology-oncology: a practical perspective.
@en
prefLabel
The evolving role of biosimilars in haematology-oncology: a practical perspective.
@ast
The evolving role of biosimilars in haematology-oncology: a practical perspective.
@en
P2860
P356
P1476
The evolving role of biosimilars in haematology-oncology: a practical perspective.
@en
P2093
Pere Gascon
P2860
P304
P356
10.1177/2040620715613715
P577
2015-12-01T00:00:00Z